Advertisement

Neuroradiology

, Volume 50, Issue 7, pp 589–597 | Cite as

Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients

  • Vasilios Katsaridis
  • Chrysanthi Papagiannaki
  • Enrico Aimar
Interventional Neuroradiology

Abstract

Introduction

Onyx has emerged in the recent years as a new embolic material. We present our experience with Onyx in the curative embolization of brain cerebral arteriovenous malformations (AVMs).

Methods

We retrospectively reviewed the files of all patients that we had treated with Onyx embolic material for a brain AVM during the last 4 years. We identified 101 patients who underwent a total of 219 sessions of embolization.

Results

The treatment has been concluded in 52 patients; in this group, total occlusion was obtained in 28 (53.9%) patients and near-total occlusion was obtained in 18 (34.6%). The respective figures based on the 101 patients of the study cohort are 28/101 (27.7%) and 18/101 (17.8%). More embolization sessions are to be carried out on the remaining 49 patients. There were three deaths, and eight patients had permanent neurological deficits with a resulting morbidity of 8% and mortality of 3%.

Conclusion

High rates of total or near-total occlusion of brain AVMs can be achieved with multiple sessions of Onyx embolization with acceptable morbidity and mortality

Keywords

Arteriovenous malformation Brain Embolization Onyx 

Notes

Conflict of interest statement

We declare that we have no conflict of interest.

References

  1. 1.
    Brothers MF, Kaufmann JC, Fox AJ et al. (1989) n-Butyl 2-cyanoacrylate-substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. AJNR Am J Neuroradiol 10:777–786PubMedGoogle Scholar
  2. 2.
    Yamashita K, Taki W, Iwata H et al. (1994) Characteristics of ethylene vinyl alcohol copolymer (EVAL) mixtures. AJNR Am J Neuroradiol 15:1103–1105PubMedGoogle Scholar
  3. 3.
    Henkes H, Nahser HC, Berg-Dammer E et al. (1998) Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res 20:479–492PubMedGoogle Scholar
  4. 4.
    Jafar JJ, Davis AJ, Berenstein A et al. (1993) The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 78:60–69PubMedGoogle Scholar
  5. 5.
    Murayama Y, Vinuela F, Ulhoa A et al. (1998) Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 43:1164–1175PubMedCrossRefGoogle Scholar
  6. 6.
    Paulsen RD, Steinberg GK, Norbash AM et al. (1999) Embolization of rolandic cortex arteriovenous malformations. Neurosurgery 44:479–484PubMedCrossRefGoogle Scholar
  7. 7.
    Jahan R, Murayama Y, Gobin YP et al. (2001) Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 48:984–995PubMedCrossRefGoogle Scholar
  8. 8.
    n-BCA Trail Investigators (2002) n-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 23:748–755Google Scholar
  9. 9.
    Taylor CL, Dutton K, Rappard G et al. (2004) Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg 100:810–812PubMedGoogle Scholar
  10. 10.
    Weber W, Kis B, Siekman R, Kuehne D (2007) Endovascular treatment of intracranial arteriovenous malformations with Onyx: Technical aspects. AJNR Am J Neuroradiol 28:371–377PubMedGoogle Scholar
  11. 11.
    van Rooij WJ, Sluzewski M, Beute GN (2007) Brain AVM Embolization with Onyx. AJNR Am J Neuroradiol 28:172–177PubMedGoogle Scholar
  12. 12.
    Mounayer C, Hammami N, Piotin M et al. (2007) Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 28:518–523PubMedGoogle Scholar
  13. 13.
    Chyatte D (1997) Normal pressure perfusion breakthrough after resection of arteriovenous malformation. J Stroke Cerebrovasc Dis 6:130–136PubMedCrossRefGoogle Scholar
  14. 14.
    Kato Y, Sano H, Nonomura K et al. (1997) Normal perfusion pressure breakthrough syndrome in giant arteriovenous malformations. Neurol Res 19:117–123PubMedGoogle Scholar
  15. 15.
    Day AL, Friedman WA, Sypert GW, Mickle JP (1982) Successful treatment of the normal perfusion pressure breakthrough syndrome. Neurosurgery 11:625–630PubMedCrossRefGoogle Scholar
  16. 16.
    Debrun GM, Aletich V, Ausman JI et al. (1997) Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 40:112–120PubMedCrossRefGoogle Scholar
  17. 17.
    Fournier D, TerBrugge KG, Willinsky R et al. (1991) Endovascular treatment of intracerebral arteriovenous malformations: experience in 49 cases. J Neurosurg 75:228–233PubMedCrossRefGoogle Scholar
  18. 18.
    Deruty R, Pelissou-Guyotat I, Mottolese C et al. (1993) The combined management of cerebral arteriovenous malformations. Experience with 100 cases and review of the literature. Acta Neurochir (Vienna) 123:101–112CrossRefGoogle Scholar
  19. 19.
    Wilms G, Goffin J, Plets C et al (1993) Embolization of arteriovenous malformations of the brain: preliminary experience. J Belge Radiol 76:299–303PubMedGoogle Scholar
  20. 20.
    Liu HM, Huang YC, Wang YH (2000) Embolization of cerebral arteriovenous malformations with n-butyl-cyanoacrylate. J Formos Med Assoc 99:906–913PubMedGoogle Scholar
  21. 21.
    Meisel HJ, Mansmann U, Alvarez H et al. (2002) Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir (Vienna) 144:879–887CrossRefGoogle Scholar
  22. 22.
    Wikholm G, Lundquist C, Svendsen P (2001) The Goteborg cohort of embolized cerebral arteriovenous malformations: a 6-year follow-up. Neurosurgery 49:799–805PubMedCrossRefGoogle Scholar
  23. 23.
    Cronquist M, Wirestam R, Ramgren B et al. (2006) Endovascular treatment of intracerebral arteriovenous malformations: procedural safety, complications and results evaluated by MR imaging, including diffusion and perfusion imaging. AJNR Am J Neuroradiol 27:162–176Google Scholar
  24. 24.
    Haw CS, terBrugge K, Wllinsky R, Tomlinson G (2006) Complications of embolization of arteriovenous malformations of the brain. J Neurosurg 104:226–232PubMedCrossRefGoogle Scholar
  25. 25.
    DeMeritt JS, Pile-Spellman J, Mast H (1995) Outcome analysis of preoperative embolization with n-butyl cyanoacrylate in cerebral arteriovenous malformations. AJNR Am J Neuroradiol 16:1801–1807PubMedGoogle Scholar
  26. 26.
    Frizzel RT, Fisher WS 3rd (1995) Cure, morbidity and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period. Neurosurgery 37:1039–1040CrossRefGoogle Scholar
  27. 27.
    Valavanis A, Yasargil MG (1998) The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 24:131–140PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Vasilios Katsaridis
    • 1
  • Chrysanthi Papagiannaki
    • 1
  • Enrico Aimar
    • 1
  1. 1.Neurosurgical Department“G. Papanikolaou” General HospitalThessalonikiGreece

Personalised recommendations